That was my understanding till I was shown what biotech stocks get bought out for,
the triangle report shows $5 billion of you divided that by shares on issues
(163 mill) you get just over $30 but what the triangle report does not show is that generally big pharma will add 3 to 5 times peak sale so if we go in the middle that will be 4 times 5 billion = 20 bill divided by shares on issue 163m you get
Just over $122 a share and I know that sounds insane but even Dr T said the triangle report was very very conservative.
So if we get to positive phase 3 then it's top end that's why I'll take triangles report offer for lesser trials
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-69
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.055(3.07%) |
Mkt cap ! $297.9M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.79 | $1.72 | $134.5K | 76.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9898 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 600 | 1 |
View Market Depth
| Last trade - 14.02pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
-0.055 ( 0.95 %) |
||||
| Open | High | Low | Volume | ||
| $1.76 | $1.77 | $1.72 | 19420 | ||
| Last updated 14.01pm 17/06/2024 ? | |||||
| RAC (ASX) Chart |
